Decoy Therapeutics, Inc. (DCOY)
0.702
+0.02
(+2.93%)
USD |
NASDAQ |
Feb 26, 16:00
0.6966
-0.01
(-0.77%)
After-Hours: 19:04
Decoy Therapeutics EPS Diluted (Quarterly) : -1.814 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Eli Lilly & Co. | 7.024 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.8735M |
| Total Expenses (Quarterly) | 0.8735M |
| Enterprise Value | -0.4557M |
| Earnings Yield | -3.54K% |
| Normalized Earnings Yield | -3539.33 |